000			01731 a2200517 4500
005			20250516183755.0
264		0	_c20140123
008			201401s 0 0 rus d
022			_a1997-7298
040			_aNLM _beng _cNLM
100	1		_aPopova, E V
245	0	0	_a[The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis]. _h[electronic resource]
260			_bZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _c2013
300			_a93-6 p. _bdigital
500			_aPublication Type: Comparative Study; English Abstract; Journal Article; Randomized Controlled Trial
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aChild
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInjections, Subcutaneous
650	0	4	_aInterferon beta-1b
650	0	4	_aInterferon-beta _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMoscow
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aRecombinant Proteins
650	0	4	_aRetrospective Studies
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aBoĭko, A N
700	1		_aDavydovskaia, M V
700	1		_aDemina, T L
700	1		_aKukel', T M
700	1		_aLashch, N Iu
700	1		_aPopova, N F
700	1		_aKhachanova, N V
700	1		_aShchur, S G
700	1		_aGusev, E I
773	0		_tZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova _gvol. 113 _gno. 10 Pt 2 _gp. 93-6
999			_c23331758 _d23331758